Monte Rosa Therapeutics, Inc. Common Stock (GLUE) News

Latest headlines that mention GLUE, newest first · each headline opens the original publisher

GLUE quote

Last price: $10.32
Day change: +1.47%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

GLUE headlines

latest coverage

Seeking Alpha News 3d ago

Monte Rosa Therapeutics, Inc. (GLUE) Discusses GFORCE-1 Phase I Results for NEK7 Molecular Glue Degrader MRT-8102 in Cardiovascular Disease Risk - Slideshow

General T2GLUE

Seeking Alpha News 7d ago

Monte Rosa Therapeutics, Inc. (GLUE) Discusses GFORCE-1 Phase I Results for NEK7 Molecular Glue Degrader MRT-8102 in Cardiovascular Disease Risk Transcript

General T2GLUE

Yahoo Finance 25d ago

Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone

General T2GLUE NVS

Seeking Alpha News 1mo ago

Monte Rosa Therapeutics: High-Stakes Drug Pipeline Balanced By A Fortress Balance Sheet

General T2GLUE

Investing.com 2mo ago

Why is Monte Rosa Therapeutics stock plunging today?

General T3GLUE

Investing.com 2mo ago

Form 144 MONTE ROSA THERAPEUTICS For: 16 July

General T3GLUE

Investing.com 3mo ago

Monte Rosa Therapeutics CSO Sharon Townson sells shares worth $139,849

General T3GLUE

Investing.com 3mo ago

Form 144 MONTE ROSA THERAPEUTICS For: 23 June

General T3GLUE

Yahoo Finance 4mo ago

Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy

General T2GLUE

Investing.com 4mo ago

Form 144 Monte Rosa Therapeutics For: 1 June

General T3GLUE

Seeking Alpha 5mo ago

Monte Rosa Therapeutics reports Q1 results

Earnings T2GLUE

Also mentioned with GLUE

30d

NVS1

Headlines that tag both tickers

GLUE news alerts

Get an alert by email or push when a new headline mentions GLUE.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.